Undiagnosed, untreated blood disorders in women and young girls have medical consequences and unique issues at every life stage, creating the need for a foundation dedicated to education and awareness.
We work to achieve this goal by raising awareness and educating the key healthcare providers for each particular life stage and translating and disseminating provider information and research.
The Foundation for Women & Girls with Blood Disorders is proud to announce the recent appointment of its newest board members, Sarah O’Brien, MD, MSc and Jeffrey H. Lawson, MD, PhD.
The Anticoagulation Forum has issued new interim clinical guidance on thromboembolism and anticoagulant therapy during the COVID-19.
ISTH has issued interim guidance for the diagnosis and treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT) and is designed to inform the management of suspected thrombosis in subjects who have recently received the AstraZeneca or Johnson & Johnson vaccines.
Please join NHF for its April Webinar Series on Wednesdays from 2-3 pm ET on a range of topics of interest to the blood disorder community.
Join the American Heart Association, American Society of Health System Pharmacists, and the Anticoagulation Forum on Thursday, March 18, at 1 pm ET for a webinar on Structural Racism as a Fundamental Driver of Health Disparities.
Join faculty Dr. Jim Bussel and Dr. Andra James for our next FWGBD webinar, Case-Based Conversation on FNAIT: Fetal and Neonatal Thrombocytopenia on Wednesday, May 12, 2021, from 12:00-1:00 pm ET.
Dr. Jim Bussel commented on the rare incidence of patients who received the COVID-19 vaccine and developed ITP in a recent New York Times article to help providers identify the best therapies for treatment and improve patient care.
Dr. Lisa Baumann Kreuziger, MD, MS, Medical Director at the Versiti Blood Center of Wisconsin, was praised by White House advisor and director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, for her leadership on a national COVID-19 panel that recommends the best treatment options for people with the virus.
On Thursday, February 25, 2021, from 2:00-3:00 PM EST, the CDC will be hosting a webinar on the new clinical practice guidelines for the diagnosis and management of von Willebrand Disease (VWD), developed in concert by ASH, ISTH, NHF, WFH, and UKMC.
